Plasma Transfusions: Evidence-Based Guidelines

The use of plasma has significantly increased over the past several decades.  It is generally accepted that a significant proportion of plasma transfusions are inappropriate.  Learn what evidence based guidelines have to say about common clinical uses of plasma for bleeding or prevention of bleeding.


TARGET AUDIENCE / PREREQUISITES
This activity has been designed for general, specialty, and subspecialty physicians who prescribe blood products and for hospital transfusion service Medical Directors. There are no participant prerequisites for this activity.



CME CREDITS: 1.0 AMA PRA Category 1 Credit(s)TM

Enter Course

LEARNING OBJECTIVES
At the conclusion of this activity, participants should be able to:

  1. Cite common indications and the rationale for plasma 
  2. Describe current evidence-based guidelines on plasma use
  3. Discuss the potential risks and alternatives to plasma in various clinical settings

LEARNING TASKS
To receive CME credit for this activity, participants must:

  1. Acknowledge their review of activity prerequisites, objectives, disclosures, methods of physician participation and statements.
  2. Review the presentation "Plasma Transfusions: Evidence-Based Guidelines" or read the PowerPoint slides and accompanying notes available as a printable Adobe Reader® file.
  3. Take the online Post-Test.
  4. Complete the online Activity Evaluation.
  5. Print the certificate awarding 1.0 AMA PRA Category 1 credit(s)TM through the SUCCESSTM program.

FACULTY
Mary Ellen Wissel, MD
Great Lakes Chief Medical Officer
American Red Cross Blood Services
Columbus OH

ACTIVITY PLANNER
Mary Ellen Wissel, MD
Great Lakes Chief Medical Officer
American Red Cross Blood Services
Columbus, OH


LEARNING REFERENCES

  1. Tinmouth A. Evidence for a rational use of frozen plasma for the treatment and prevention of bleeding. Transfus Apher Sci 2012;46:293-298.
  2. Goodnough LT, Shander A. How I treat warfarin-associated coagulopathy in patients with intracerebral hemorrhagne. Blood 2011;117:6091-6099.
  3. Dzik WS. Reversal of drug-induced anticoagulation: old solutions and new problems. Transfusion 2012;52:45S-55S.

DISCLOSURES
Activity faculty and planners have indicated that they have no relevant financial relationships with commercial interests to disclose. No commercial support was received for this activity.

DISCLAIMER
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the American Red Cross Biomedical Services. Information herein is presented for educational purposes only and not to endorse off-label use. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

ACCREDITATION STATEMENT
The American Red Cross Biomedical Services (ARCBS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

DESIGNATION STATEMENT
The American Red Cross Biomedical Services designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™; physicians should only claim credit commensurate with the extent of their participation in the activity.

PASSING REQUIREMENTS
TheIf your correctly answer 70% or more of the post-test items you may claim credit.

DISCLOSURE STATEMENT
All faculty participating in ARCBS continuing medical education programs are expected to disclose to learners whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s); faculty are also expected to disclose off-label and/or investigational uses of products under discussion.

RELEASE DATE: 07/12/2013

EXPIRATION DATE: 07/11/2018

ESTIMATED TIME TO COMPLETE ACTIVITY: 1.0 hour(s)

Last modified: Wednesday, June 6, 2018, 04:24 PM